Wedescribe a familial occurrence of primary hyperparathyroidism. The proband is a 60-yearold womanwho had a parathyroid adenoma. Her older sister had a parathyroid adenoma with cementifying jaw fibroma and her younger sister died of parathyroid adenocarcinoma with pulmonarymetastasis at the age of 38.
Introduction
Familial primary hyperparathyroidism was first reported by Goldman and Smith ( 1 ) and then by several investigators (2-8).
It is widely known that the occurrence of familial hyperparathyroidism is not rare in Europe (6-9), however, this disorderis not commonin Japan (10-16). It is not clearwhether familial hyperparathyroidism is a partial symptomof MENor not. There is widespread acceptance that multiple involvement of parathyroid glands is much more commonin all family forms of hyperparathyroidism (6, 7). However, various families with hyperparathyroidism have been reported, in which affected members have parathyroid single adenoma (6-8) or cancer (9, 15 0.028 (familial hypocalciuric hypercalcemia: <0.01). Endocrine studies did not reveal any abnormalities concerning the pituitary, thyroid and adrenal glands or the pancreas (Table 2) . Ultrasonogram of her neck showed a hypoechoic mass (15 by 6 mm), adjacent to the upper portion of the right thyroid gland. Radiographic examination showedevidence of multiple metastases due to Wilms' tumor over bilateral lung fields. Mild demineralization of the entire skeleton was observed. Computer tomogramrevealed normal appearances of the pituitary and adrenal glands and the pancreas, and these seemed to be no association with MEN. At surgery a swelling parathyroid gland with a size of 14 by 16 by 1 1 mmwas removed. There was no enlargement of other parathyroid glands. Pathological examination of a surgically obtained tissue revealed chief cell adenoma. Her postoperative course was not eventful and her serum calcium, phosphorus and PTH levels were decreased, however, hypocalcemia was not observed. Seven days after the operation, her serum calcium level was 8.9 mg/dl, phosphorus 3.3 mg/dl, c-PTH 0.43 ng/ml, m-PTH 8 19 pg/ml, and int-PTH 49.6 pg/ml. Two years after the operation her serum calcium and phosphorus levels are normal.
Family Studies
Her pedigree is shown in Fig. 1 . There is no history of consanguinity in this family. Her older sister (case 2) underwent surgery for parathyroid adenoma at the age of 60. Her serum calcium was 1 1.6 mg/dl, phosphorus was 2.0 mg/dl and serum m-PTH was 4,700 pg/ml (16). She had complication of cementifyingjaw fibroma. Her serum calcium, phosphorus and PTHreturned to normal levels after the operation. No diseases associated with multiple endocrine neoplasia were observed during her postoperative course. The proband' s younger sister (case 3) died at the age of 38 because ofadenocarcinoma of the parathyroid gland with pulmonary metastases. Her serum calcium was 16.4 mg/dl, phosphorus was 2.4 mg/dl, and serum CPTHwas elevated to 9.9 ng/ml. She may have involvement of more than one parathyroid gland.
However, her serum calcium and phosphorus are maintained within normal levels and there is no evidence of hyperparathyroidism at 2 years after the operation. She had an 8-year history of hypercalcemia, however, she did not have any symptoms due to hypercalcemia and her bone demineralization was mild, which may be related to her age. In familial hyperparathyroidism there is a lack of symptoms due to hypercalcemia and the absence of bone disease (8). Therefore, it is necessary to measure the serumcalcium in order to identify any other affected family members.
Familial hypocalciuric hypercalcemia is also a familial disorder that presents hypercalcemia and hypophosphatemia in multiple members ofakindred ( 17, 1 8). In familial hypocalciuric hypercalcemia, the onset of hypercalcemia occurs in early life, symptomsof chronic hypercalcemia are vague or mild, the pathology of the parathyroid glands shows hyperplasia, and there is a high relapse rate after the removal of one or two parathyroid glands. The biochemical analysis shows a low value for the ratio of calcium clearance to creatinine clearance (17, 18). The disorder observed in the present family can be clearly distinguished from a familial hypocalciuric hypercalcemia.
It is not clear whether familial primary hyperparathyroidism is a separate syndrome or a partial expression of MEN. However, there are several reports that affected membersdo not have other endocrine disorders (6-8).
Wehave not yet found any evidence for other endocrine disorders in this family. The parathyroid pathology of the affected members in our family is single adenomain two cases and adenocarcinomain one case. Chief cell hyperplasia of the parathyroid glands is the most commonpathological entity in MEN,whereas chief cell adenoma and hyperplasia are in familial hyperparathyroidism (6-9). However,the histological distinction between parathyroid adenoma and hyperplasia is difficult. The study ofclonality will provide important clues to clarify the origin of parathyroid adenoma. Parathyroid adenomas have the DNAhybridization pattern of monoclonality, however, parathyroid hyperplasia does not have monoclonality (19), suggesting that parathyroid tumors observed in MENare polyclonal hyperplasia. Recent studies (20, 21) indicated that many hyperplastic parathyroid tumors in MENtype 1 are monoclonal and monoclonal developmentof those tumors is associated with the loss of most or all of the chromosome1 1. There are two other types of familial hyperparathyroidism. In one type the affected family membershave ossifying jaw fibroma (22, 23), and in the other type they have parathyroid cancer (24). It is not clear whether these disorders are associated with hyperparathyroidism of MEN.In the present family, the older sister had hyperparathyroidism with cementifying fibroma of the jaw and the younger one had parathyroid cancer. Tumor development in MENtype 1 occurs as a result of the deletion or inactivation of both copies of wild-type genetic locus (chromosome I lql3) resembling those documented in retinoblastoma (25) . Recent studies have not demonstrated any abnormalities on chromosome1 1 in parathyroid tumors obtained from hyperparathyroid families withjaw fibroma (23) or from a kindred of parathyroid cancer (21). These suggest that the disorders seem to be distinct from MENtype 1. However, somesporadic adenomahave DNArearrangement of an allele on chromosome1 1 whichmayrelate withMENtype1 gene and PTH gene (Ilpl5) on chromosome ll (26, 27 ). The present case was complicated with Wilms' tumor. The occurrence of Wilms' tumor in patients with familial hyperparathyroidism has not been reported. Inactivation of chromosome1 Ipl3 and 1 Ipl5 is associated with the development ofWilms' tumor (28, 29) . Therefore, it seems that this family has mutational abnormalities on chromosome 1 1, resulting in the development of various tumors amongfamily members. It will be necessary to carefully follow this pedigree in the future. 
